Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Brain Edema | 47 | 2024 | 604 | 10.740 |
Why?
|
Glyburide | 19 | 2024 | 116 | 6.090 |
Why?
|
Stroke | 55 | 2024 | 9758 | 4.890 |
Why?
|
Brain Ischemia | 22 | 2023 | 3049 | 2.140 |
Why?
|
Subarachnoid Hemorrhage | 9 | 2021 | 1033 | 1.950 |
Why?
|
Cerebral Infarction | 8 | 2022 | 983 | 1.480 |
Why?
|
Infarction, Middle Cerebral Artery | 5 | 2024 | 485 | 1.420 |
Why?
|
Hypoglycemic Agents | 10 | 2019 | 3085 | 1.330 |
Why?
|
Diffusion Magnetic Resonance Imaging | 10 | 2024 | 2791 | 1.230 |
Why?
|
Cerebral Hemorrhage | 20 | 2023 | 2656 | 1.220 |
Why?
|
Neuroprotective Agents | 4 | 2021 | 957 | 1.050 |
Why?
|
Matrix Metalloproteinase 9 | 6 | 2022 | 632 | 1.030 |
Why?
|
Endopeptidases | 11 | 2003 | 774 | 0.970 |
Why?
|
Intracranial Hemorrhages | 2 | 2021 | 822 | 0.830 |
Why?
|
Reperfusion | 4 | 2024 | 271 | 0.830 |
Why?
|
Hypoxanthine | 1 | 2022 | 28 | 0.830 |
Why?
|
Infarction, Anterior Cerebral Artery | 2 | 2019 | 12 | 0.810 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36426 | 0.790 |
Why?
|
Hepatic Encephalopathy | 2 | 2020 | 144 | 0.790 |
Why?
|
Fast Foods | 1 | 2024 | 211 | 0.790 |
Why?
|
Endothelin-1 | 1 | 2022 | 302 | 0.730 |
Why?
|
Spinal Cord Neoplasms | 1 | 2023 | 263 | 0.720 |
Why?
|
Brain Infarction | 3 | 2021 | 290 | 0.710 |
Why?
|
Cerebrum | 2 | 2019 | 132 | 0.710 |
Why?
|
Amyloid beta-Protein Precursor | 9 | 2005 | 1111 | 0.690 |
Why?
|
Anterior Cerebral Artery | 1 | 2019 | 50 | 0.670 |
Why?
|
Malates | 1 | 2019 | 34 | 0.650 |
Why?
|
Cerebral Amyloid Angiopathy | 4 | 2022 | 895 | 0.640 |
Why?
|
Ammonia | 1 | 2020 | 237 | 0.640 |
Why?
|
Tissue Plasminogen Activator | 5 | 2021 | 1164 | 0.640 |
Why?
|
Galectin 3 | 1 | 2020 | 240 | 0.630 |
Why?
|
Ketoglutaric Acids | 1 | 2019 | 76 | 0.620 |
Why?
|
Metabolomics | 3 | 2024 | 1659 | 0.610 |
Why?
|
Succinic Acid | 1 | 2019 | 86 | 0.610 |
Why?
|
Middle Cerebral Artery | 1 | 2019 | 275 | 0.610 |
Why?
|
Liver Failure, Acute | 1 | 2020 | 181 | 0.600 |
Why?
|
Telomerase | 1 | 2023 | 745 | 0.590 |
Why?
|
Hypertension | 7 | 2024 | 8540 | 0.590 |
Why?
|
Reperfusion Injury | 3 | 2021 | 1023 | 0.580 |
Why?
|
Intracranial Embolism | 1 | 2019 | 189 | 0.570 |
Why?
|
Brain Injuries | 4 | 2022 | 2054 | 0.560 |
Why?
|
Blast Injuries | 3 | 2024 | 322 | 0.500 |
Why?
|
Humans | 126 | 2024 | 761596 | 0.500 |
Why?
|
Critical Care | 7 | 2022 | 2697 | 0.500 |
Why?
|
Water | 3 | 2023 | 1411 | 0.490 |
Why?
|
Cerebral Revascularization | 1 | 2017 | 259 | 0.470 |
Why?
|
Aged | 46 | 2024 | 169310 | 0.470 |
Why?
|
Extremities | 1 | 2019 | 867 | 0.460 |
Why?
|
Third Ventricle | 1 | 2014 | 74 | 0.450 |
Why?
|
Fibrinolytic Agents | 5 | 2021 | 2084 | 0.450 |
Why?
|
Ventriculoperitoneal Shunt | 1 | 2014 | 188 | 0.430 |
Why?
|
Middle Aged | 51 | 2024 | 220921 | 0.430 |
Why?
|
Hydrocephalus | 2 | 2023 | 764 | 0.430 |
Why?
|
Heart Atria | 1 | 2019 | 1345 | 0.410 |
Why?
|
Male | 59 | 2024 | 360846 | 0.410 |
Why?
|
Brain | 15 | 2024 | 27121 | 0.410 |
Why?
|
Hematoma | 4 | 2022 | 767 | 0.400 |
Why?
|
Carnitine | 2 | 2023 | 252 | 0.390 |
Why?
|
Recovery of Function | 4 | 2020 | 2979 | 0.390 |
Why?
|
Coronary Disease | 2 | 2024 | 5914 | 0.370 |
Why?
|
Female | 58 | 2024 | 392705 | 0.370 |
Why?
|
Recurrence | 1 | 2023 | 8466 | 0.360 |
Why?
|
Endovascular Procedures | 4 | 2022 | 2183 | 0.360 |
Why?
|
Tomography, X-Ray Computed | 11 | 2023 | 20568 | 0.360 |
Why?
|
Diet | 3 | 2024 | 8075 | 0.360 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2013 | 269 | 0.350 |
Why?
|
Hemoglobins | 2 | 2014 | 1526 | 0.350 |
Why?
|
Military Personnel | 3 | 2024 | 1246 | 0.340 |
Why?
|
Hypoglycemia | 2 | 2016 | 883 | 0.330 |
Why?
|
Drainage | 1 | 2014 | 1157 | 0.320 |
Why?
|
Intensive Care Units | 5 | 2022 | 3744 | 0.300 |
Why?
|
Membrane Proteins | 11 | 2003 | 7859 | 0.300 |
Why?
|
Aged, 80 and over | 17 | 2024 | 58984 | 0.300 |
Why?
|
Glioma | 1 | 2023 | 3455 | 0.300 |
Why?
|
Alzheimer Disease | 6 | 2024 | 8601 | 0.290 |
Why?
|
Risk Factors | 17 | 2024 | 74213 | 0.290 |
Why?
|
Diet, Mediterranean | 2 | 2024 | 740 | 0.280 |
Why?
|
Retrospective Studies | 23 | 2024 | 80647 | 0.270 |
Why?
|
Incidence | 6 | 2024 | 21355 | 0.270 |
Why?
|
Amyloid Precursor Protein Secretases | 11 | 2003 | 620 | 0.270 |
Why?
|
Aspartic Acid Endopeptidases | 9 | 2003 | 311 | 0.270 |
Why?
|
Prognosis | 15 | 2022 | 29629 | 0.270 |
Why?
|
Neurology | 3 | 2023 | 780 | 0.260 |
Why?
|
Treatment Outcome | 16 | 2024 | 64685 | 0.260 |
Why?
|
Mitogen-Activated Protein Kinase 10 | 1 | 2005 | 9 | 0.260 |
Why?
|
Data Collection | 2 | 2012 | 3322 | 0.250 |
Why?
|
Cricetinae | 10 | 2005 | 2423 | 0.240 |
Why?
|
Membrane Glycoproteins | 4 | 2003 | 3701 | 0.240 |
Why?
|
Functional Laterality | 1 | 2011 | 2257 | 0.230 |
Why?
|
Food Handling | 1 | 2024 | 154 | 0.220 |
Why?
|
Rats, Wistar | 2 | 2021 | 1848 | 0.220 |
Why?
|
Critical Illness | 2 | 2015 | 2723 | 0.220 |
Why?
|
Betaine | 1 | 2023 | 90 | 0.220 |
Why?
|
Optic Chiasm | 1 | 2023 | 91 | 0.210 |
Why?
|
Brain Diseases | 1 | 2012 | 1546 | 0.210 |
Why?
|
Adult | 29 | 2024 | 221210 | 0.200 |
Why?
|
Cohort Studies | 8 | 2024 | 41495 | 0.200 |
Why?
|
Sex Characteristics | 1 | 2013 | 2639 | 0.200 |
Why?
|
Pseudouridine | 1 | 2022 | 19 | 0.200 |
Why?
|
Guanosine | 1 | 2022 | 48 | 0.200 |
Why?
|
Cardiopulmonary Resuscitation | 2 | 2022 | 993 | 0.200 |
Why?
|
Edema | 2 | 2023 | 766 | 0.200 |
Why?
|
Blood-Brain Barrier | 3 | 2024 | 1027 | 0.190 |
Why?
|
Intracranial Pressure | 1 | 2024 | 324 | 0.190 |
Why?
|
Double-Blind Method | 6 | 2024 | 12341 | 0.190 |
Why?
|
Prospective Studies | 16 | 2024 | 54423 | 0.190 |
Why?
|
Nucleosides | 1 | 2022 | 131 | 0.190 |
Why?
|
Pilot Projects | 6 | 2024 | 8633 | 0.190 |
Why?
|
Choline | 1 | 2023 | 515 | 0.190 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2024 | 269 | 0.190 |
Why?
|
Cerebral Amyloid Angiopathy, Familial | 1 | 2021 | 54 | 0.190 |
Why?
|
Clinical Trials as Topic | 6 | 2020 | 8002 | 0.190 |
Why?
|
Quadriplegia | 1 | 2023 | 226 | 0.190 |
Why?
|
Infusions, Subcutaneous | 1 | 2021 | 43 | 0.190 |
Why?
|
Thrombolytic Therapy | 3 | 2021 | 2064 | 0.190 |
Why?
|
Siderosis | 1 | 2022 | 103 | 0.190 |
Why?
|
Receptors, Peptide | 1 | 2022 | 279 | 0.180 |
Why?
|
Severity of Illness Index | 8 | 2019 | 15843 | 0.180 |
Why?
|
Injections, Intravenous | 2 | 2021 | 1379 | 0.180 |
Why?
|
Factor VIIa | 1 | 2021 | 103 | 0.180 |
Why?
|
Heart Arrest | 2 | 2022 | 1514 | 0.180 |
Why?
|
Patient Admission | 3 | 2019 | 1367 | 0.180 |
Why?
|
Glutamine | 1 | 2023 | 577 | 0.180 |
Why?
|
Receptors, Interleukin-1 | 1 | 2021 | 262 | 0.180 |
Why?
|
Choroid Plexus | 1 | 2023 | 240 | 0.170 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2024 | 2242 | 0.170 |
Why?
|
Atrial Fibrillation | 1 | 2019 | 5127 | 0.170 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2001 | 436 | 0.170 |
Why?
|
Peptide Fragments | 7 | 2005 | 5112 | 0.170 |
Why?
|
Inflammation | 1 | 2019 | 10774 | 0.170 |
Why?
|
CHO Cells | 8 | 2003 | 1387 | 0.170 |
Why?
|
Endpoint Determination | 2 | 2020 | 590 | 0.160 |
Why?
|
Vasospasm, Intracranial | 2 | 2014 | 215 | 0.160 |
Why?
|
Clinical Trials, Phase II as Topic | 2 | 2019 | 629 | 0.160 |
Why?
|
Triterpenes | 1 | 2019 | 76 | 0.160 |
Why?
|
Time Factors | 9 | 2019 | 39969 | 0.160 |
Why?
|
Animals | 27 | 2024 | 168475 | 0.160 |
Why?
|
Disability Evaluation | 4 | 2019 | 1836 | 0.160 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2020 | 296 | 0.160 |
Why?
|
Receptors, IgG | 2 | 2019 | 559 | 0.150 |
Why?
|
Antioxidants | 2 | 2019 | 1668 | 0.150 |
Why?
|
Drugs, Chinese Herbal | 1 | 2019 | 144 | 0.150 |
Why?
|
Image Interpretation, Computer-Assisted | 3 | 2019 | 3359 | 0.150 |
Why?
|
Out-of-Hospital Cardiac Arrest | 1 | 2022 | 339 | 0.150 |
Why?
|
Predictive Value of Tests | 7 | 2022 | 15266 | 0.140 |
Why?
|
Hypothermia, Induced | 1 | 2022 | 753 | 0.140 |
Why?
|
Patient Care Management | 1 | 2020 | 302 | 0.140 |
Why?
|
Embolectomy | 1 | 2018 | 129 | 0.140 |
Why?
|
Longitudinal Studies | 3 | 2022 | 14608 | 0.140 |
Why?
|
Central Nervous System Diseases | 1 | 2021 | 520 | 0.140 |
Why?
|
Databases, Factual | 1 | 2012 | 7968 | 0.140 |
Why?
|
United States | 11 | 2024 | 72340 | 0.140 |
Why?
|
Case-Control Studies | 3 | 2022 | 22176 | 0.140 |
Why?
|
Immunity | 1 | 2022 | 996 | 0.140 |
Why?
|
Prostheses and Implants | 1 | 2023 | 1271 | 0.140 |
Why?
|
Cerebrospinal Fluid | 1 | 2019 | 544 | 0.130 |
Why?
|
Caenorhabditis elegans Proteins | 1 | 2003 | 874 | 0.130 |
Why?
|
Multivariate Analysis | 5 | 2016 | 12059 | 0.130 |
Why?
|
Rats | 4 | 2021 | 23741 | 0.130 |
Why?
|
Presenilin-1 | 8 | 2003 | 660 | 0.120 |
Why?
|
Chromatography, Liquid | 1 | 2019 | 983 | 0.120 |
Why?
|
Disease Models, Animal | 3 | 2024 | 18255 | 0.120 |
Why?
|
Neuroradiography | 1 | 2015 | 71 | 0.120 |
Why?
|
Presenilin-2 | 4 | 2003 | 95 | 0.120 |
Why?
|
Amyloid beta-Peptides | 5 | 2000 | 3839 | 0.120 |
Why?
|
Spinal Cord | 1 | 2023 | 1819 | 0.120 |
Why?
|
Pituitary Neoplasms | 1 | 2023 | 1323 | 0.120 |
Why?
|
Ventriculostomy | 1 | 2015 | 131 | 0.110 |
Why?
|
Metabolome | 1 | 2021 | 989 | 0.110 |
Why?
|
Cross-Sectional Studies | 4 | 2023 | 26129 | 0.110 |
Why?
|
Soft Tissue Infections | 1 | 2015 | 168 | 0.110 |
Why?
|
Homeodomain Proteins | 1 | 2003 | 2418 | 0.110 |
Why?
|
Netherlands | 1 | 2018 | 2221 | 0.110 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 426 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5247 | 0.110 |
Why?
|
Point-of-Care Systems | 1 | 2022 | 1213 | 0.100 |
Why?
|
Decompressive Craniectomy | 1 | 2013 | 76 | 0.100 |
Why?
|
Tandem Mass Spectrometry | 1 | 2019 | 1188 | 0.100 |
Why?
|
Receptors, Drug | 1 | 2012 | 157 | 0.100 |
Why?
|
Thrombectomy | 3 | 2022 | 705 | 0.100 |
Why?
|
Cricetulus | 2 | 2005 | 814 | 0.100 |
Why?
|
Reproducibility of Results | 7 | 2023 | 20100 | 0.100 |
Why?
|
Manometry | 1 | 2014 | 454 | 0.100 |
Why?
|
Drosophila Proteins | 1 | 2001 | 1699 | 0.100 |
Why?
|
Hippocampus | 1 | 2024 | 3766 | 0.100 |
Why?
|
Hyperglycemia | 1 | 2020 | 1376 | 0.100 |
Why?
|
Cerebellar Diseases | 1 | 2014 | 220 | 0.100 |
Why?
|
Potassium Channels, Inwardly Rectifying | 1 | 2012 | 144 | 0.100 |
Why?
|
Follow-Up Studies | 4 | 2023 | 39106 | 0.090 |
Why?
|
Aldosterone | 1 | 2016 | 870 | 0.090 |
Why?
|
Interleukin-6 | 1 | 2021 | 3208 | 0.090 |
Why?
|
Brain Concussion | 1 | 2022 | 1404 | 0.090 |
Why?
|
Forced Expiratory Volume | 1 | 2016 | 1814 | 0.090 |
Why?
|
Inflammation Mediators | 1 | 2019 | 1886 | 0.090 |
Why?
|
Positive-Pressure Respiration | 1 | 2014 | 639 | 0.090 |
Why?
|
Saline Solution, Hypertonic | 1 | 2011 | 114 | 0.090 |
Why?
|
Mannitol | 1 | 2011 | 180 | 0.090 |
Why?
|
Monocytes | 1 | 2019 | 2570 | 0.090 |
Why?
|
Survival Analysis | 2 | 2020 | 10090 | 0.080 |
Why?
|
Solubility | 2 | 2020 | 1091 | 0.080 |
Why?
|
Device Removal | 1 | 2014 | 630 | 0.080 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.080 |
Why?
|
Tracheostomy | 1 | 2013 | 426 | 0.080 |
Why?
|
Cerebrovascular Circulation | 1 | 2019 | 2727 | 0.080 |
Why?
|
Graft vs Host Disease | 1 | 2022 | 3029 | 0.080 |
Why?
|
Cerebral Ventricles | 1 | 2012 | 542 | 0.080 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2012 | 563 | 0.080 |
Why?
|
American Heart Association | 1 | 2014 | 1039 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3222 | 0.080 |
Why?
|
Eclampsia | 1 | 2009 | 56 | 0.080 |
Why?
|
Esophagus | 1 | 2014 | 1033 | 0.080 |
Why?
|
Signal Transduction | 5 | 2021 | 23447 | 0.080 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4415 | 0.080 |
Why?
|
Quality of Life | 4 | 2023 | 13367 | 0.080 |
Why?
|
Coma | 2 | 2022 | 484 | 0.080 |
Why?
|
Internal Medicine | 1 | 2015 | 1051 | 0.080 |
Why?
|
Logistic Models | 3 | 2019 | 13255 | 0.080 |
Why?
|
TRPM Cation Channels | 2 | 2020 | 139 | 0.080 |
Why?
|
Craniotomy | 1 | 2012 | 741 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2226 | 0.080 |
Why?
|
Disease Progression | 5 | 2016 | 13510 | 0.070 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2024 | 9001 | 0.070 |
Why?
|
Cerebral Angiography | 1 | 2013 | 1281 | 0.070 |
Why?
|
Receptors, Notch | 2 | 2003 | 744 | 0.070 |
Why?
|
Aspartic Acid | 2 | 2000 | 576 | 0.070 |
Why?
|
Protein Structure, Tertiary | 2 | 2005 | 3792 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5799 | 0.070 |
Why?
|
Lung | 2 | 2016 | 10002 | 0.070 |
Why?
|
Cytokines | 1 | 2021 | 7396 | 0.070 |
Why?
|
Echocardiography | 1 | 2019 | 4989 | 0.070 |
Why?
|
Postoperative Care | 1 | 2012 | 1468 | 0.070 |
Why?
|
Surgical Wound Infection | 1 | 2015 | 1529 | 0.070 |
Why?
|
Puerperal Disorders | 1 | 2009 | 300 | 0.070 |
Why?
|
Heart Diseases | 1 | 2019 | 2781 | 0.060 |
Why?
|
Neurons | 1 | 2005 | 9463 | 0.060 |
Why?
|
Mass Spectrometry | 1 | 2013 | 2192 | 0.060 |
Why?
|
Electrocardiography | 1 | 2019 | 6377 | 0.060 |
Why?
|
Respiratory Insufficiency | 1 | 2013 | 1230 | 0.060 |
Why?
|
Threonine | 1 | 2005 | 271 | 0.060 |
Why?
|
Hydrolysis | 2 | 2003 | 664 | 0.060 |
Why?
|
Intracranial Aneurysm | 1 | 2014 | 1285 | 0.060 |
Why?
|
Blood Glucose | 2 | 2016 | 6391 | 0.060 |
Why?
|
Survival Rate | 1 | 2018 | 12723 | 0.060 |
Why?
|
MicroRNAs | 1 | 2020 | 3816 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2014 | 1277 | 0.060 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2024 | 134 | 0.060 |
Why?
|
Decompression | 1 | 2023 | 36 | 0.060 |
Why?
|
Education, Medical, Graduate | 1 | 2015 | 2373 | 0.050 |
Why?
|
Explosions | 1 | 2023 | 108 | 0.050 |
Why?
|
Medical Audit | 1 | 2024 | 453 | 0.050 |
Why?
|
Patient Discharge | 2 | 2014 | 3443 | 0.050 |
Why?
|
Neurosurgical Procedures | 1 | 2014 | 2072 | 0.050 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12690 | 0.050 |
Why?
|
Up-Regulation | 2 | 2016 | 4125 | 0.050 |
Why?
|
Curriculum | 1 | 2015 | 3743 | 0.050 |
Why?
|
Quality Assurance, Health Care | 1 | 2012 | 2169 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2003 | 1693 | 0.050 |
Why?
|
Substrate Specificity | 2 | 2003 | 1791 | 0.050 |
Why?
|
Intracranial Hypertension | 1 | 2024 | 193 | 0.050 |
Why?
|
Subcellular Fractions | 1 | 2002 | 532 | 0.050 |
Why?
|
Binding, Competitive | 1 | 2003 | 1141 | 0.050 |
Why?
|
Connecticut | 1 | 2022 | 364 | 0.050 |
Why?
|
Sheep | 1 | 2024 | 1440 | 0.050 |
Why?
|
CREB-Binding Protein | 1 | 2001 | 148 | 0.050 |
Why?
|
Gluconates | 1 | 2020 | 31 | 0.050 |
Why?
|
Young Adult | 4 | 2024 | 59260 | 0.050 |
Why?
|
Golgi Apparatus | 2 | 2000 | 405 | 0.040 |
Why?
|
Specific Gravity | 1 | 2020 | 18 | 0.040 |
Why?
|
Half-Life | 1 | 2001 | 651 | 0.040 |
Why?
|
Blood Pressure Determination | 1 | 2024 | 633 | 0.040 |
Why?
|
Eucommiaceae | 1 | 2019 | 4 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2001 | 238 | 0.040 |
Why?
|
Glasgow Coma Scale | 1 | 2022 | 580 | 0.040 |
Why?
|
Pentacyclic Triterpenes | 1 | 2019 | 35 | 0.040 |
Why?
|
Metalloendopeptidases | 1 | 2001 | 393 | 0.040 |
Why?
|
Mutation | 3 | 2023 | 30053 | 0.040 |
Why?
|
Recombinant Proteins | 3 | 2021 | 6534 | 0.040 |
Why?
|
Glycosylation | 1 | 2002 | 1097 | 0.040 |
Why?
|
Smoking | 1 | 2016 | 9053 | 0.040 |
Why?
|
Osmolar Concentration | 1 | 2020 | 659 | 0.040 |
Why?
|
HeLa Cells | 2 | 2003 | 3094 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 3 | 2001 | 1974 | 0.040 |
Why?
|
Ferritins | 1 | 2021 | 598 | 0.040 |
Why?
|
Length of Stay | 1 | 2012 | 6426 | 0.040 |
Why?
|
National Institutes of Health (U.S.) | 1 | 2022 | 793 | 0.040 |
Why?
|
Adenovirus E4 Proteins | 1 | 1997 | 7 | 0.040 |
Why?
|
Adenovirus E1B Proteins | 1 | 1997 | 14 | 0.040 |
Why?
|
Biological Evolution | 1 | 2003 | 1071 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2019 | 212 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2019 | 17904 | 0.040 |
Why?
|
Corpus Callosum | 1 | 2022 | 751 | 0.040 |
Why?
|
Aquaporin 4 | 1 | 2018 | 161 | 0.040 |
Why?
|
Oligopeptides | 1 | 2003 | 1187 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2022 | 1869 | 0.040 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2020 | 411 | 0.040 |
Why?
|
Sensitivity and Specificity | 1 | 2012 | 14665 | 0.030 |
Why?
|
Biomedical Research | 1 | 2012 | 3429 | 0.030 |
Why?
|
Protein Sorting Signals | 1 | 1997 | 279 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 2000 | 754 | 0.030 |
Why?
|
Adolescent | 3 | 2024 | 88326 | 0.030 |
Why?
|
Mississippi | 1 | 2016 | 95 | 0.030 |
Why?
|
Cells, Cultured | 3 | 2012 | 18966 | 0.030 |
Why?
|
Neutrophils | 2 | 2022 | 3767 | 0.030 |
Why?
|
Mice | 6 | 2024 | 81539 | 0.030 |
Why?
|
Cognition Disorders | 1 | 2009 | 3980 | 0.030 |
Why?
|
Hospitals | 2 | 2021 | 3883 | 0.030 |
Why?
|
Phantoms, Imaging | 1 | 2023 | 2526 | 0.030 |
Why?
|
Blood Pressure | 2 | 2024 | 8481 | 0.030 |
Why?
|
Uric Acid | 1 | 2020 | 807 | 0.030 |
Why?
|
Administration, Oral | 1 | 2022 | 4021 | 0.030 |
Why?
|
North America | 1 | 2018 | 1276 | 0.030 |
Why?
|
Recombinant Fusion Proteins | 1 | 2003 | 3733 | 0.030 |
Why?
|
Phosphorylation | 1 | 2005 | 8321 | 0.030 |
Why?
|
Mice, Inbred C57BL | 2 | 2024 | 22174 | 0.030 |
Why?
|
Nicardipine | 1 | 2012 | 60 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 1998 | 1134 | 0.030 |
Why?
|
Consensus | 1 | 2022 | 3124 | 0.030 |
Why?
|
Protein Binding | 2 | 2001 | 9353 | 0.020 |
Why?
|
Tetracycline | 1 | 2012 | 216 | 0.020 |
Why?
|
Survivors | 1 | 2022 | 2371 | 0.020 |
Why?
|
Trans-Activators | 1 | 2001 | 2856 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2003 | 13446 | 0.020 |
Why?
|
Cell Line | 2 | 2002 | 15601 | 0.020 |
Why?
|
Hospital Mortality | 2 | 2016 | 5293 | 0.020 |
Why?
|
Peptides | 1 | 2003 | 4358 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2001 | 2986 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10554 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2003 | 17635 | 0.020 |
Why?
|
Microsomes | 2 | 2000 | 251 | 0.020 |
Why?
|
Dimerization | 2 | 2002 | 891 | 0.020 |
Why?
|
Hemorrhage | 1 | 2021 | 3424 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6312 | 0.020 |
Why?
|
Calcium Channel Blockers | 1 | 2012 | 694 | 0.020 |
Why?
|
Risk Assessment | 2 | 2024 | 23996 | 0.020 |
Why?
|
Headache Disorders, Primary | 1 | 2009 | 39 | 0.020 |
Why?
|
ROC Curve | 1 | 2016 | 3578 | 0.020 |
Why?
|
Cell Nucleus | 1 | 1997 | 2910 | 0.020 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12149 | 0.020 |
Why?
|
Rats, Sprague-Dawley | 1 | 2019 | 8181 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2811 | 0.020 |
Why?
|
Drug Synergism | 1 | 2012 | 1757 | 0.020 |
Why?
|
Nanoparticles | 1 | 2019 | 1958 | 0.020 |
Why?
|
Cell Differentiation | 1 | 2005 | 11530 | 0.020 |
Why?
|
Positron-Emission Tomography | 1 | 2024 | 6484 | 0.020 |
Why?
|
Exercise | 1 | 2024 | 5890 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3415 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9319 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 2014 | 1779 | 0.020 |
Why?
|
Transfection | 3 | 2000 | 5774 | 0.020 |
Why?
|
Anticoagulants | 1 | 2022 | 4812 | 0.020 |
Why?
|
Cognition | 1 | 2024 | 6992 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3688 | 0.020 |
Why?
|
Vasoconstriction | 1 | 2009 | 592 | 0.020 |
Why?
|
Linear Models | 1 | 2016 | 5872 | 0.020 |
Why?
|
Autoantibodies | 1 | 1994 | 2118 | 0.020 |
Why?
|
Electroencephalography | 1 | 2021 | 6237 | 0.020 |
Why?
|
Heparin | 1 | 2012 | 1634 | 0.020 |
Why?
|
Genetic Variation | 1 | 2020 | 6567 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2009 | 1835 | 0.010 |
Why?
|
Cholic Acids | 1 | 2003 | 39 | 0.010 |
Why?
|
Reoperation | 1 | 2012 | 4303 | 0.010 |
Why?
|
Pneumonia | 1 | 2013 | 2143 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2012 | 14417 | 0.010 |
Why?
|
Cytoplasm | 2 | 1997 | 1510 | 0.010 |
Why?
|
Odds Ratio | 1 | 2013 | 9647 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12463 | 0.010 |
Why?
|
Aspirin | 1 | 2012 | 3133 | 0.010 |
Why?
|
Affinity Labels | 1 | 2000 | 107 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10721 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9610 | 0.010 |
Why?
|
Peptide Hydrolases | 1 | 2003 | 624 | 0.010 |
Why?
|
Models, Chemical | 1 | 2002 | 611 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2012 | 3549 | 0.010 |
Why?
|
Electrochemistry | 1 | 1999 | 145 | 0.010 |
Why?
|
Comorbidity | 1 | 2013 | 10508 | 0.010 |
Why?
|
Coenzymes | 1 | 1999 | 102 | 0.010 |
Why?
|
Cell-Free System | 1 | 1999 | 340 | 0.010 |
Why?
|
Intracellular Fluid | 1 | 1998 | 201 | 0.010 |
Why?
|
Gene Products, rex | 1 | 1997 | 6 | 0.010 |
Why?
|
Molecular Weight | 1 | 2000 | 2186 | 0.010 |
Why?
|
Gene Products, rev | 1 | 1997 | 29 | 0.010 |
Why?
|
COS Cells | 1 | 1999 | 1130 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2015 | 7406 | 0.010 |
Why?
|
Antigens, Polyomavirus Transforming | 1 | 1997 | 257 | 0.010 |
Why?
|
Macromolecular Substances | 1 | 1998 | 1434 | 0.010 |
Why?
|
Seizures | 1 | 2009 | 2957 | 0.010 |
Why?
|
Protein Folding | 1 | 1999 | 870 | 0.010 |
Why?
|
Respiratory Burst | 1 | 1994 | 110 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12973 | 0.010 |
Why?
|
Exons | 1 | 1999 | 2391 | 0.010 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1994 | 445 | 0.010 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 1994 | 289 | 0.010 |
Why?
|
Binding Sites | 1 | 2000 | 6056 | 0.010 |
Why?
|
Brain Neoplasms | 1 | 2012 | 9032 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2012 | 15633 | 0.010 |
Why?
|
Vasculitis | 1 | 1994 | 521 | 0.010 |
Why?
|
Cell Membrane | 1 | 1999 | 3687 | 0.010 |
Why?
|
RNA, Viral | 1 | 1997 | 2846 | 0.000 |
Why?
|
Ligands | 1 | 1994 | 3272 | 0.000 |
Why?
|
Pregnancy | 1 | 2009 | 29890 | 0.000 |
Why?
|
Reactive Oxygen Species | 1 | 1994 | 2139 | 0.000 |
Why?
|
Mice, Transgenic | 1 | 1998 | 9542 | 0.000 |
Why?
|
Carrier Proteins | 1 | 1997 | 4937 | 0.000 |
Why?
|
Immunohistochemistry | 1 | 1997 | 11076 | 0.000 |
Why?
|
Kidney | 1 | 1998 | 7048 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1997 | 12794 | 0.000 |
Why?
|